|
EPS8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.67340000032124E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.05649999999569E-05 |
| Normal-vs-Stage2 |
3.519600E-02 |
| Normal-vs-Stage3 |
8.153800E-02 |
| Normal-vs-Stage4 |
2.288400E-01 |
| Stage1-vs-Stage2 |
9.363600E-01 |
| Stage1-vs-Stage3 |
6.930400E-01 |
| Stage1-vs-Stage4 |
5.156400E-01 |
| Stage2-vs-Stage3 |
7.166000E-01 |
| Stage2-vs-Stage4 |
4.629600E-01 |
| Stage3-vs-Stage4 |
7.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.72009999869161E-08 |
| Normal-vs-AfricanAmerican |
2.370200E-02 |
| Normal-vs-Asian |
6.333000E-01 |
| Caucasian-vs-AfricanAmerican |
5.861700E-02 |
| Caucasian-vs-Asian |
1.714810E-01 |
| AfricanAmerican-vs-Asian |
3.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.1635999960028E-08 |
| Normal-vs-Female |
2.357800E-03 |
| Male-vs-Female |
4.956400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.974500E-02 |
| Normal-vs-Extreme_Weight |
3.361500E-03 |
| Normal-vs-Obese |
2.562200E-04 |
| Normal-vs-Extreme_Obese |
2.606800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.146400E-01 |
| Normal_Weight-vs-Obese |
5.232000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.211800E-01 |
| Extreme_Weight-vs-Obese |
6.584400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.145600E-01 |
| Obese-vs-Extreme_Obese |
5.910000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.041900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.53799999957904E-07 |
| Normal-vs-Age(61-80Yrs) |
2.199700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.743160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.084830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.685600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.557400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.657600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.835600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.43770037278557E-10 |
| Normal-VS-Type2 PRCC |
3.284400E-02 |
| Normal-VS-KIRP CIMP |
7.470500E-02 |
| Normal-VS-Unclassified PRCC |
8.403200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.004120E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.9530999999805E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
7.490800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.061000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.568160E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.162000E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.065500E-02 |
| Normal-vs-N1 |
6.870300E-02 |
| Normal-vs-N2 |
2.233400E-01 |
| N0-vs-N1 |
3.656800E-01 |
| N0-vs-N2 |
5.796200E-01 |
| N1-vs-N2 |
9.488800E-01 |
|
|
